Active, Not Recruiting
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
NCT06081894
- Conditions
- Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- UC San Diego Health - Sulpizio Cardiovascular Center La Jolla, California, United States
- Keck Medical Center of USC (Outpatient Clinic) Los Angeles, California, United States
- Cedars-Sinai Medical Center (Smidt Heart Institute) Los Angeles, California, United States